Bitrobius Genetics is developing the Gentrafix™ platform to solve the major problem with gene therapy: the inability of therapeutic genes to reach most of the cells in an affected organ or tissue. It promises to revolutionise the treatment of genetic diseases.
Company Details
- Employees
- 6
- Founded
- -
- Address
- Alderley Park, Congleton Road,united Kingdom
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.bitrobius.com
- Keywords
- Alderley Edge.
- HQ
- Macclesfield, Cheshire
Bitrobius Genetics Questions
Bitrobius Genetics's website is http://www.bitrobius.com
Bitrobius Genetics's LinkedIn profile is https://uk.linkedin.com/company/bitrobius-genetics
Bitrobius Genetics has
6 employees.
View email and phone details for 6
employees at Bitrobius Genetics.
Bitrobius Genetics's industry is
Biotechnology Research
Bitrobius Genetics's top competitors are
Bivictrix Therapeutics Ltd,
Stream Bio,
Monument Therapeutics,
Artelo Biosciences, Inc.,
Pencil Biosciences Limited,
Infex Therapeutics,
Bruntwood Scitech,
Gentronix, Part Of Scantox Group,
Apex Molecular Ltd,
Apconix.
Bitrobius Genetics's categories are Biotechnology Research
Bitrobius Genetics's founding year is 2020
